SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041368
Filing Date
2019-11-07
Accepted
2019-11-07 07:51:40
Documents
67
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atra-10q_20190930.htm   iXBRL 10-Q 2918617
2 EX-10.1 atra-ex101_105.htm EX-10.1 93036
3 EX-10.2 atra-ex102_106.htm EX-10.2 92859
4 EX-10.3 atra-ex103_107.htm EX-10.3 341280
5 EX-10.4 atra-ex104_104.htm EX-10.4 491745
6 EX-10.5 atra-ex105_108.htm EX-10.5 81122
7 EX-10.6 atra-ex106_109.htm EX-10.6 25472
8 EX-31.1 atra-ex311_7.htm EX-31.1 16117
9 EX-31.2 atra-ex312_6.htm EX-31.2 16150
10 EX-32.1 atra-ex321_9.htm EX-32.1 8044
  Complete submission text file 0001564590-19-041368.txt   10827958

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA atra-20190930.xsd EX-101.SCH 52735
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atra-20190930_cal.xml EX-101.CAL 69732
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atra-20190930_def.xml EX-101.DEF 179027
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20190930_lab.xml EX-101.LAB 468350
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20190930_pre.xml EX-101.PRE 335770
18 EXTRACTED XBRL INSTANCE DOCUMENT atra-10q_20190930_htm.xml XML 1856231
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 191198178
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences